CLINICAL_TRIALS
trial_result
· 2022-02-03
Clinical Trial Update: Cardiopulmonary Bypass Prime Solution in Patients Undergoing Heart Valve Surgery [Phase 3]
Summary
Phase 3 clinical trial update for a cardiopulmonary bypass prime solution in patients undergoing heart valve surgery has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Rajaie Cardiovascular Medical and Research Center | Conditions: Heart Valve Diseases | Phase 3 | Status: COMPLETED